Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression-Reference-Cited by-同舟云学术

Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression

Published:2024-03 Issue: Volume:348 Page:143-151
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Parikh Sagar V.,Vande Voort Jennifer L.,Yocum Anastasia K.,Achtyes Eric,Goes Fernando S.,Nykamp Louis,Singh Balwinder,Lopez-Vives Daniela,Sera Cortney E.,Maixner Daniel,Tarnal Vijay,Severe Jennifer,Bartek Steven,Tye Susannah J.,Rico Jose,Stoppel Cynthia J.,Becerra Alexis,Smart LeAnn,Miller Christina R.,Frye Mark A.,Greden John F.,Bobo William V.

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference47 articles.

1. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression;Aan Het Rot;Biol. Psychiatry,2010

2. Diagnostic and Statistical Manual of Mental Disorders,2013

3. Assessment of suicidal intention: the Scale for Suicide Ideation;Beck;J. Consult. Clin. Psychol.,1979

4. Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy;Caddy;Ther. Adv. Psychopharmacol.,2014

5. Bipolar disorder;Carvalho;N. Engl. J. Med.,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous (IV) ketamine versus intranasal esketamine for depression– Advantage IV ketamine?;Journal of Affective Disorders;2024-07

2. Change in neurocognitive functioning in patients with treatment-resistant depression with serial intravenous ketamine infusions: The Bio-K multicenter trial;Psychiatry Research;2024-05